Chloroacetic Acid

Chloroacetic Acid

SCHEMBL23933668

O=C(O)CCl.O=C1CCC(=O)N1O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.32
POLB P06746 1/20 0.32
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31
LMNA P02545 1/20 0.30
NPC1 O15118 1/20 0.30
TTR P02766 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylene Chloride SCHEMBL28020824 0.85 POLB (0.31) POLBLMNA
Succinic Acid SCHEMBL28916613 0.83 LMNA (0.45) TSHRCA12CA1CA9ALDH1A1
Succinic Acid SCHEMBL722926 0.83 LMNA (0.45) TSHRCA12CA1CA9ALDH1A1
SCHEMBL6742810 0.82 CA12 (0.35) CA12CA1CA9ALDH1A1PKM
1,2-Dichloroethane SCHEMBL28194159 0.82 POLB (0.31) POLB
Bicarbonate SCHEMBL14917 0.82 CA1 (0.38) TSHRCA12CA1CA9ALDH1A1
Bicarbonate SCHEMBL6150295 0.82 CA1 (0.38) TSHRCA12CA1CA9ALDH1A1
Thioglycolic Acid SCHEMBL7061183 0.81 TSHR (0.33) TSHRCA12CA1CA9ALDH1A1
Propionic Acid SCHEMBL1518988 0.81 FFAR3 (0.48) TSHRCA12CA1CA9ALDH1A1
Glycine SCHEMBL1681950 0.81 GLRA1 (0.48) TSHRCA12CA1CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242586-A1 RAS INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-08-03 US disclosed
EP-4138875-A1 RAS INHIBITORS AND USES THEREOF The Regents of the University of California (US) 2023-03-01 EP disclosed
WO-2021217019-A1 RAS INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242586-A1 RAS INHIBITORS AND USES THEREOF KRAS, NRAS, HRAS TSHR 3074/4885CA12 3997/4885CA1 4528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.